Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Cytokinetics Inc (CYTK) – Cytokinetics Inc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Cytokinetics (CYTK) trades at $82.19, up 1.72% on the day, supported by a bullish technical signal and strong analyst consensus. The stock's momentum follows the successful U.S. launch and recent European launch of its heart drug MYQORZO, which is driving revenue growth. However, the company remains in a heavy investment phase, evidenced by significant operating losses and negative profit margins, as it scales commercial operations.
The outlook hinges on MYQORZO's commercial execution to offset high cash burn. The 94% analyst buy rating and a $108.60 consensus price target suggest substantial upside potential, but investment carries high risk due to persistent losses, a high P/S ratio of 94, and dependence on a single product's market adoption for a path to profitability.
Read full analysis

Key Stats

  • Market Cap
    $11.14B
  • Sector
    Technology
  • 3M Drawdown
    -14.85%
  • Enterprise Value
    $11.61B
  • Dividend Yield
    -
  • Typical Hold Time
    11 days
$82.19
52W Low: $33.04
30 Jun 2025
52W High: $82.19
26 Jun 2026

Cytokinetics Inc (CYTK) is currently valued at a market capitalization of $11.14B, with an enterprise value of $11.61B. Over the past 52 weeks, Cytokinetics Inc has traded between a low of $33.04 and a high of $82.19, highlighting its annual price range. Over the past three months, Cytokinetics Inc has recorded a drawdown of -14.85%, reflecting recent price volatility. On average, investors hold Cytokinetics Inc for approximately 11 days, indicating typical investor behavior on the platform.

About Cytokinetics Inc

Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.


People also bought


Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

Key Stats

  • Market Cap
    $11.14B
  • Sector
    Technology
  • 3M Drawdown
    -14.85%
  • Enterprise Value
    $11.61B
  • Dividend Yield
    -
  • Typical Hold Time
    11 days
$82.19
52W Low: $33.04
30 Jun 2025
52W High: $82.19
26 Jun 2026

Cytokinetics Inc (CYTK) is currently valued at a market capitalization of $11.14B, with an enterprise value of $11.61B. Over the past 52 weeks, Cytokinetics Inc has traded between a low of $33.04 and a high of $82.19, highlighting its annual price range. Over the past three months, Cytokinetics Inc has recorded a drawdown of -14.85%, reflecting recent price volatility. On average, investors hold Cytokinetics Inc for approximately 11 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!